XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026)
XORTX Therapeutics' Operating Expenses was $178,654 in the quarter ended Jun 30, 2026, down 27.4% from $246,246 a year earlier but up 93.2% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, XORTX Therapeutics' Operating Expenses was $504,732 through Jun 30, 2026, down 35.2% year-over-year; for the year ended Dec 31, 2025, it was $584,005, up 58.4% from the prior year.
- Operating Expenses shows a five-year compound annual growth rate of 22.3% (years ended Dec 2020 to Dec 2025).
- In earlier years, Operating Expenses was $368,690 in the year ended Dec 31, 2024 (-82.2%), $2.07 million in the year ended Dec 31, 2023 (-71.3%), $7.22 million in the year ended Dec 31, 2022 (+779.4%) and $821,274 in the year ended Dec 31, 2021 (+284.5%).
- Quarterly Operating Expenses has moved between $79,769 (the quarter ended Dec 31, 2024) and $2.59 million (the quarter ended Mar 31, 2022) over five years.
- Compared with a year earlier, Operating Expenses was higher in four of the last eight quarters, with growth averaging 9.6%.
- The best year-over-year quarter for Operating Expenses over five years was the quarter ended Sep 30, 2022 (growth of 398.1%); the worst was the quarter ended Dec 31, 2023 (a decline of 88.6%).
- Per Business Quant data, XRTX's Operating Expenses in the three quarters before the quarter ended Jun 30, 2026 was $92,463 (quarter ended Mar 31, 2026), $115,479 (quarter ended Dec 31, 2025) and $118,136 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | XORTX Therapeutics | 1.62 Mn | -1.68 Mn | - | 178,654.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178,654.00 |
| Mar 31, 2026 | 92,463.00 |
| Dec 31, 2025 | 115,479.00 |
| Sep 30, 2025 | 118,136.00 |
| Jun 30, 2025 | 246,246.00 |
| Mar 31, 2025 | 336,106.00 |
| Dec 31, 2024 | 79,769.00 |
| Sep 30, 2024 | 116,506.00 |
| Jun 30, 2024 | 159,941.00 |
| Mar 31, 2024 | 110,250.56 |
| Dec 31, 2023 | 167,253.00 |
| Sep 30, 2023 | 492,204.46 |
| Jun 30, 2023 | 564,452.79 |
| Mar 31, 2023 | 849,508.73 |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 2.59 Mn |
| Dec 31, 2021 | 522,875.82 |
| Sep 30, 2021 | 244,787.70 |
API Access
XORTX Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();